2,224
Views
17
CrossRef citations to date
0
Altmetric
Research Articles

Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2

, , &
Pages 685-695 | Received 06 Jul 2020, Accepted 27 Aug 2020, Published online: 10 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meryem Boutalaka, Salma El bahi, Marwa Alaqarbeh, Moulay Ahfid El Alaouy, Yassine Koubi, Khalil El Khatabi, Hamid Maghat, Mohammed Bouachrine & Tahar Lakhlifi. (2023) Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now

Articles from other publishers (16)

MERIEM AMRANE, SALYHA OUKID & TOLGA ENSARI. (2022) MOLECULES GENERATION TO INHIBIT COVID-19 DISEASE USING ENCODER-DECODER LSTM ARCHITECTURE AND PCA PROPERTIES. Journal of Mechanics in Medicine and Biology 23:01.
Crossref
Robert Adamu Shey, Stephen Mbigha Ghogomu, Derrick Neba Nebangwa, Cabirou Mounchili Shintouo, Ntang Emmaculate Yaah, Bernis Neneyoh Yengo, Francis Nongley Nkemngo, Kevin Kum Esoh, Nelly Manuela Tatchou Tchatchoua, Tekoh Terriss Mbachick, Api Fon Dede, Arnaud Azonpi Lemoge, Roland Akwelle Ngwese, Bertha Fru Asa, Lawrence Ayong, Rose Njemini, Luc Vanhamme & Jacob Souopgui. (2022) Rational design of a novel multi-epitope peptide-based vaccine against Onchocerca volvulus using transmembrane proteins. Frontiers in Tropical Diseases 3.
Crossref
Soukaina Bouamrane, Ayoub Khaldan, Halima Hajji, Reda El-mernissi, Marwa Alaqarbeh, Nada Alsakhen, Hamid Maghat, Mohammed Aziz Ajana, Abdelouahid Sbai, Mohammed Bouachrine & Tahar Lakhlifi. (2022) In silico identification of 1,2,4-triazoles as potential Candida Albicans inhibitors using 3D-QSAR, molecular docking, molecular dynamics simulations, and ADMET profiling. Molecular Diversity.
Crossref
Paul Andrei Negru, Denisa Claudia Miculas, Tapan Behl, Alexa Florina Bungau, Ruxandra-Cristina Marin & Simona Gabriela Bungau. (2022) Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses. Biomedicine & Pharmacotherapy 153, pages 113432.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Mariana Pereira & Nuno Vale. (2022) Saquinavir: From HIV to COVID-19 and Cancer Treatment. Biomolecules 12:7, pages 944.
Crossref
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino & Edeildo Ferreira da Silva-Júnior. (2022) Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CL pro : A Study by Applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking . Letters in Drug Design & Discovery 19:7, pages 637-653.
Crossref
K.Y. Chen, T. Krischuns, L. Ortega Varga, E. Harigua-Souiai, S. Paisant, A. Zettor, J. Chiaravalli, A. Delpal, D. Courtney, A. O'Brien, S.C. Baker, E. Decroly, C. Isel, F. Agou, Y. Jacob, A. Blondel & N. Naffakh. (2022) A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors. Antiviral Research 201, pages 105272.
Crossref
Sankalp Jain, Daniel C. Talley, Bolormaa Baljinnyam, Jun Choe, Quinlin Hanson, Wei Zhu, Miao Xu, Catherine Z. Chen, Wei Zheng, Xin Hu, Min Shen, Ganesha Rai, Matthew D. Hall, Anton Simeonov & Alexey V. Zakharov. (2021) Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants . ACS Pharmacology & Translational Science 4:5, pages 1675-1688.
Crossref
Deniz EMRE, Nuran ÖZALTIN & Selehattin YILMAZ. (2021) A review on recent electroanalytical methods for the analysis of antiviral COVID-19 drugs. Turkish Journal of Analytical Chemistry 3:1, pages 1-8.
Crossref
Jonathan M. O. Rawson, Alice Duchon, Olga A. Nikolaitchik, Vinay K. Pathak & Wei-Shau Hu. (2021) Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors. Viruses 13:2, pages 173.
Crossref
Ameneh Norouzi. (2020) Treatment of SARS-CoV-2 (COVID-19) cases by the oral administration of montelukast tablets. Bionatura 5:4, pages 1304-1308.
Crossref
Andres F. Yepes-Pérez, Oscar Herrera-Calderon, José-Emilio Sánchez-Aparicio, Laura Tiessler-Sala, Jean-Didier Maréchal & Wilson Cardona-G. (2020) Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-14.
Crossref
Rami A. Al-Horani & Srabani Kar. (2020) Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review. Viruses 12:10, pages 1092.
Crossref
Vladimir Khavinson, Natalia Linkova, Anastasiia Dyatlova, Boris Kuznik & Roman Umnov. (2020) Peptides: Prospects for Use in the Treatment of COVID-19. Molecules 25:19, pages 4389.
Crossref
Melika Lotfi, Michael R. Hamblin & Nima Rezaei. (2020) COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta 508, pages 254-266.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.